# Nova MSC subsidiary EyRIS wins RM7.13M contract for Brunei diabetic retinopathy screening

EyRIS Pte Ltd, a subsidiary of Nova MSC Berhad, secured a RM7.13 million contract from JPMCnova Sdn Bhd to launch a national diabetic retinopathy screening program in Brunei using AI platform SELENA+, starting October 2024.

- Type: Contract
- Announced: 2024-09-09
- Where: Brunei Darussalam, Brunei
- Status: announced
- Products: AI-based diabetic retinopathy screening system (SELENA+)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Nova MSC Berhad](https://endata.com/companies/79708.md)
- [EyRIS Pte Ltd](https://endata.com/companies/79709.md) (partner)
- [JPMCnova Sdn Bhd](https://endata.com/companies/79710.md) (customer)

## Sources

- [dagangnews.com](https://www.dagangnews.com/index.php/article/nova-msc-peroleh-kontrak-rm713-juta-laksanakan-program-saringan-retinopati-diabetik-kebangsaan-di-brunei-40747), 2024-09-09: "Kami berbangga dapat bekerjasama dengan KKM, Brunei dalam usaha mereka untuk memanfaatkan teknologi AI untuk mengubah cara perkhidmatan perubatan boleh disampaikan secara kos efektif."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.